Chiron to use Serenex’s Proteome Mining™ Technology
Business Review Editor
Abstract
Serenex signed a major deal with Chiron to utilize Serenex’s Proteome Mining™ technology to develop novel bioactive therapeutic candidates.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.